Drugs / Vi Polysaccharide (PS) vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01229176 Comparator | Mar 2011 → Jun 2012 | typhoid fever | Novartis | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vi Polysaccharide (PS) vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01229176 ↗ |
| Modality | Vaccine | “25 μg Vi-polysaccharide vaccine” PMID 24290843 ↗ Nov 2013 |